The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.
The Report on Competition policy, published annually, provides detailed information on the most important policy and legislative initiatives, and on decisions adopted by the European Commission in application of EU competition law during the previous year.
Every year in February, the EESC adopts an opinion on Annual Sustainable Growth Survey, which the Commission usually presents at the end of November in the year before. The Committee works under tight deadlines, in anticipation of the referral, to finalise the opinion before the March Council discussion on the topic. To reinforce the Committee's impact throughout the entire European Semester, an own-initiative opinion with additional considerations is regularly produced by October taking into account the overall European Semester, which plays a central role in implementing the Recovery and Resilience Facility and is vital in current discussions about the review of the EU macro-economic governance framework.
The EESC supports the digital euro project, while underlining the importance of a clear European legal framework able to establish the exceptional possibility of temporary exemptions for certain payees, and to harmonise practices and standards that vary from one Member State to another. It is essential to ensure that the digital euro does not negatively impact financial stability or the lending potential of credit institutions. The EESC encourages a broad public debate on the reasons for possible issuance of a digital euro, its merits and drawbacks, in order to make informed decisions and ensure public understanding of the project.